N
Google TrendANNA BONDAR (200+) — October 12, 2026: Tommy Paul vs Valentin Vacherot: Set 2 Winner Tennis Prediction Market
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:anna bondar200+natanael cano100+green card500+power outage near me10000+india2000+sony playstation1000+loki100+hubert hurkacz200+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Edwards has 10-year data" (30 stories)

Top Headline Story

Edwards Lifesciences (NYSE:EW) Stock Forecast & Analyst Predictions
Lead StorySimply Wall Streetmarkets
Oct 2

Edwards Lifesciences (NYSE:EW) Stock Forecast & Analyst Predictions

<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxNVURZUTZibGZKdmdBdVlyWVkxWVh5TkdvcnNFQkZTSTl1T2wxX0N5bENtQU5XZTN0YzZmSFBXcWJCekdncGJja0dKT2hXZHlJQk1yOXp3a2hQdDVMd3hrU29CaFBiT2NjMmtmRnRKRFdrQTlPR2k0TEdlb1ZiM1hBbnZBbE8?oc=5" target="_blank">Edwards Lifesciences (NYSE:EW) Stock Forecast & Analyst Predictions</a>  <font color="#6f6f6f">Simply Wall Street</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+19m ago

anna bondar

October 12, 2026: Tommy Paul vs Valentin Vacherot: Set 2 Winner Tennis Prediction Market

Filter stories
100+19m ago

natanael cano

Padres de Natanael Cano rompen el silencio tras retiro del cantante: "Es por el bien de nuestro hijo"

Filter stories
500+29m ago

green card

Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows

Filter stories
10000+29m ago

power outage near me

LIVE | Atlanta weather: Power outages, tree damage remain as storm threat moves east

Filter stories

Search Results for "Edwards has 10-year data"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
This Edwards innovation may have solved the leading cause of tissue valve failure
Medical Design & Outsourcingtech

This Edwards innovation may have solved the leading cause of tissue valve failure

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNMmZKWTFtN3h1eW9rNmt5Rk9MQ0RmOHBFbDYzcVlZc29rSDBsUjRtR1o0RGh3dk5OZFFWV2Zjby02V2Zrb3NIcFNRb2NMVXVnYmY5NHVScEVrRHJfSVZuZ1FYcndUSGdWeGMxc0JsSUlnVVk2YzNvSGo0NUhENEMwY0MzN0NreXhFMU5DY2pvWkJHMWVpSG13Y25oUXZoejU2UjB6SWhGLTg0WjZmV0ZTV0dacENXTGM?oc=5" target="_blank">This Edwards innovation may have solved the leading cause of tissue valve failure</a>  <font color="#6f6f6f">Medical Design & Outsourcing</font>

Read Full StoryMore like this
New 10-Year TAVI Data Generally ‘Reassuring’ but Highlight Challenges
TCTMD.comgeneral

New 10-Year TAVI Data Generally ‘Reassuring’ but Highlight Challenges

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxOTUxMVEhpcy10R2k0dDBNc3NuU1pIMmw2SUctcjNTYTRmdFViVktLa01rOGtMc1N3NmF6Q1JLQVJaRms4QkpwNzNOaU54U3RRc0lwVzRKSlpncjJzVVVZZDNMbVVCaVBkM2RnUlBkcUttMjlGYmEwbHIya2JmV29faFpKanBqSUtiY0dLNmJ2Wi13Njh2?oc=5" target="_blank">New 10-Year TAVI Data Generally ‘Reassuring’ but Highlight Challenges</a>  <font color="#6f6f6f">TCTMD.com</font>

Read Full StoryMore like this
Recent data highlight TAVR’s long-term durability: What cardiologists need to know
Cardiovascular Businessgeneral

Recent data highlight TAVR’s long-term durability: What cardiologists need to know

<a href="https://news.google.com/rss/articles/CBMimgJBVV95cUxNSVVGWDFKdjNiam1JWkVFaXdOUFNmQ1RkdXUyeXRnejZma1VoVm5CQnphUEw5UzZJUnd0SWVSR1Z4OVIwcXhUQVhGc25qWmZZRE9ESTdyenNrLUdWZ1laTllEQUlTVzZ1aHZ3Zmoxc2V2ZXlGTUNyTE1YSjd6Y0lFTGdpOUhhNWxUYm5VS2VRaTR4NWFlQVBlMTliR3pUQkE5dmllSVV5eEVBamZkd2Mtenp5aXY3eGEtRGwtNlhjUC1TYVBzTlZROC1YeGx1ZVNwY0VBcU1XUnpUSERJVjJSVHhCdXNGdVVMV1JwLW9ibmtSYjMtdGVhOWxsMjdvVnEyM2NYYURWLXptRlBYM0dtakEyVFZIVlJaU0E?oc=5" target="_blank">Recent data highlight TAVR’s long-term durability: What cardiologists need to know</a>  <font color="#6f6f6f">Cardiovascular Business</font>

Read Full StoryMore like this
TEN-YEAR PIVOTAL DATA REINFORCE THE LONG-TERM DURABILITY OF EDWARDS' RESILIA TISSUE
PR Newswiregeneral

TEN-YEAR PIVOTAL DATA REINFORCE THE LONG-TERM DURABILITY OF EDWARDS' RESILIA TISSUE

<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxQX3NadndsNUJHRGJOUnBPQ3RqN1Z3TDNnUXFXaWxobXlNa3lEM1YtSDF4b2Nwc3ctRTRnd2M0Q2FubFczZER2NjlzandPUjhucUFhTkV4X3RmZkZJR1VIb01mMTF4MGVHaWg5VmNTUUp0TmR1WDQ3YjNwTDhfNlYtbkxBRnU1b3BDb3pCNUZJanZCeXkyclFLb3pBMlN5ZHRrdTRfSGlzQl9xbXNMQ2xPNEdMbW5WSjk0MzhkYTVLbk5FNUEzdWZqOUtLVWo1RGNpcG05ZWlFcUtFRUE?oc=5" target="_blank">TEN-YEAR PIVOTAL DATA REINFORCE THE LONG-TERM DURABILITY OF EDWARDS' RESILIA TISSUE</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
Edwards has 10-year data supporting durability of Resilia tissue for heart valve tech
MassDevicetech

Edwards has 10-year data supporting durability of Resilia tissue for heart valve tech

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE5IZ2xXbFR0Mmtsb09XZDBsTHNaZTFUZFkyUWZIZWk0aEE4MThUSEJXRmk3M1hiUjlVZjF4NlVOZUpLX2ZCN3ctVVB2bDFpelNGcmF6VGFtUi1TSHNjUVRHdHBwckNRQ3VkemVOVkdSREVkLTZpY1E?oc=5" target="_blank">Edwards has 10-year data supporting durability of Resilia tissue for heart valve tech</a>  <font color="#6f6f6f">MassDevice</font>

Read Full StoryMore like this
Edwards Lifesciences Reports Second Quarter Results
Business Wirescience

Edwards Lifesciences Reports Second Quarter Results

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNMUFsUEREOXkySXNkQ0gwTmY3Rml1UTFESWl2X2pjbFRMbWttZkVVWXRQd3ozWlJ3Zm1ZRkIxUWZZYkNuTjF5T2oweU5xdzl2YWdPSWRVRnpDMGgzX0pBX2w3S01nYmJqLU1mYnEtaFlzcHR2bWFHZTYzdXdWZWdSelJ5aDg4Q1hTU3lEajlIUWFlQU9GVDZHdWVoazdsX1ZIdEYzMVF0Y3ZUV1lt?oc=5" target="_blank">Edwards Lifesciences Reports Second Quarter Results</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
10-year data raises possibility of broader tissue valve use in younger patients
Korea Biomedical Reviewtech

10-year data raises possibility of broader tissue valve use in younger patients

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1LY1A5TXRmd2gwT0N6YlVnY0xuR25ENkthZFVualRUUldXNnNYWjZ3S3BPZU9TaXRIM0c2SHRQbVpJTW9TRzVrTFZwU1ltTmxjZk1fb29lRUJpdFdTbW51VHVvcC1ray1BRV9lSWVB0gFyQVVfeXFMTW9fbUY5TS11dDBKX3pkYktISU9KaDJZZGdQSTNrTHZRc09YVVdhczROR1lWNm9ua0pDVXNzOGVNSzlHbFJmSkJaQ3BGN1ZYOVFEUU5rSGdqUDhxNERwdEZVYUpvSmxYeVNSLVJYaHpPbDRR?oc=5" target="_blank">10-year data raises possibility of broader tissue valve use in younger patients</a>  <font color="#6f6f6f">Korea Biomedical Review</font>

Read Full StoryMore like this
Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
MedTech Intelligencescience

Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue

<a href="https://news.google.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?oc=5" target="_blank">Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue</a>  <font color="#6f6f6f">MedTech Intelligence</font>

Read Full StoryMore like this
Resilia tissue developed by Edwards Lifesciences associated with long-term durability
Cardiovascular Businessscience

Resilia tissue developed by Edwards Lifesciences associated with long-term durability

<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxNN2N4NGYzbmVVWHJXOWNWLVBpZFFSUDJLTTh0bk1LMTMyaHZmS1VueUtBT3J0T1JSUUNHYmFYcERfMmEzUF9ZYzNyTmtiMmFRODV4ZlN2TjQwS3FGOWlrejZTSU01S19fd1B0Q3NJbTl1MUx2MkdIcWJYTmp0TnphZTc3M2R2a2l2R3BxclMwRFBOdTE5UWZwREdobkpYY2dkVlBOTjBqelVUNWIxbmJKSzZtdUtrVzBnZGZ4Uy14bnR1SDR4SU9WLVY4LXl5cl9TOFUyTVZIeURRTUJH?oc=5" target="_blank">Resilia tissue developed by Edwards Lifesciences associated with long-term durability</a>  <font color="#6f6f6f">Cardiovascular Business</font>

Read Full StoryMore like this
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue
Business Wirescience

Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue

<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxQQnFIS3pNclVucHNZYy1XWkoxbkN6OTU1WVgxVFVYeHMxT2lHbWN4ODlhTkt1cnh1X3h4aUN4TmZYeTV6ekxPQU5BX2lWdEc5RXhDRFZKWVVnQ3Z2UTllay1VRVVtV3hVMzFrYVZ5elNQbklsMkRCSlYwUlJJVFFscnlRb1JrWDVhNmR6RktxZ3BVRTdmbHdpUnkwcEhDb09sbmNFaUY1UHJ3RDhURklFS001QWk1dDhKdF9POEVoWGd2OHE5azE5eW5hYVJIVXNxZHc3bEllUHhjb1ZURTl5YmRQdTI?oc=5" target="_blank">Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Edwards Lifesciences Reports First Quarter Results
Business Wirescience

Edwards Lifesciences Reports First Quarter Results

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPQ2VFcFUtaUxOR1ZMMW5ELUR3ZmlKZzBWNlprdWNOTy1saDNZMTJRZERxTVM5VUE1LTFUbFMza0J1VU5ab0tLMzBkYlY4RFNSd3RaQ3NhTkgtUUtBcURXMXlfTDltenB4X2dyWnN0U0E4UzZFSmlUc1JnYVBtWjRKaDkxT1BxTnJTNE43OTNsdGFaYk1ielVxX3pMNFN0anlCeDZyLWg3OGh1NTQ?oc=5" target="_blank">Edwards Lifesciences Reports First Quarter Results</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Here’s Why Edwards Lifesciences Stock Could Reach $150
TIKR.commarkets

Here’s Why Edwards Lifesciences Stock Could Reach $150

<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxNalVFM0s4eGpaZVZ6UlhCcVc0OFVsOXBIQmZtYk92S3I4alVrUlNPUnJ0ZGNWSE52NE5ON2tsQXpjaHUzSS1Zd2xVWERPcXp3SnJtUElBVHgzT2c1cGg0M2U1U2JnZlp4WWpLV0NSOFEyV1NrVVNibU5kazJyeHVKNTVOU2o?oc=5" target="_blank">Here’s Why Edwards Lifesciences Stock Could Reach $150</a>  <font color="#6f6f6f">TIKR.com</font>

Read Full StoryMore like this
Why Reverb’s big data can help tell interesting stories about the guitar market
Guitar.commarkets

Why Reverb’s big data can help tell interesting stories about the guitar market

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE9ZY1JNTDVqSE1xRVpDM1hiOGg5MG9mUFNCay1QRnBHUEJ3YTBxLVZlR1pSY1AyTXFfUjlCUVNDSG51STFHa0t3aDRsSzFhckpnQnh6bVFBUEc0R0dGYXVYX1doOVh2cERCcl9xZWc0MDhPSzRrV1E?oc=5" target="_blank">Why Reverb’s big data can help tell interesting stories about the guitar market</a>  <font color="#6f6f6f">Guitar.com</font>

Read Full StoryMore like this
RCT, Real-world Data Show TAVI Durability Up to 7 Years in Low-risk Patients
TCTMD.comworld

RCT, Real-world Data Show TAVI Durability Up to 7 Years in Low-risk Patients

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxPWTg3LXBCQ3NZQUhEWEEwcHRpQkU1eTRFU3dsWlFFQzlPM2doa2RtTVBOTjR1R25JclJ0VzdPTDFTcXB3QjNlYWJKM0lIYTF4SFVjS2c5b3FkRmFJZkZSMmY2RGdnNVNkdlA0Vlk4bHVsM2hnckdwTmtXbWVMRVhzbkI3T3Z6SFZoZWhrQVJVdndqU2djck04Tw?oc=5" target="_blank">RCT, Real-world Data Show TAVI Durability Up to 7 Years in Low-risk Patients</a>  <font color="#6f6f6f">TCTMD.com</font>

Read Full StoryMore like this
PARTNER 3 update: TAVR still comparable to SAVR in low-risk patients after 7 years
Cardiovascular Businessgeneral

PARTNER 3 update: TAVR still comparable to SAVR in low-risk patients after 7 years

<a href="https://news.google.com/rss/articles/CBMi7AFBVV95cUxPcHQ3VFhCZ3VzMXBJamU0UGVnOGswZE01WE1Yb1M4ZWpsYnpkdkk1ZlUteVdmeFAzSy1xdU02QzktVjdKQ3IzbHJBa0FqRHNZeEZfZzZuR2d2bEhsS2Rnb2JvMTlrdEFvbmRHYjM5ZTBFdnRZSHRTM1pJdEpDeVIwTWxmaXJKMl9ZMXAtWGgzLXR3dGs0M3cwZHhwcTFZTzJSLTdJcVNrbGNCVUM5c0lTRFp1Z0FfYTJjZkFOR0tLamdXVWVPUGNXRU82UFlyNkxGRkZMSE9ZZmtXMFJKdi1XcVRBcDBnSENDV1BvSQ?oc=5" target="_blank">PARTNER 3 update: TAVR still comparable to SAVR in low-risk patients after 7 years</a>  <font color="#6f6f6f">Cardiovascular Business</font>

Read Full StoryMore like this
Edwards Lifesciences Reports Fourth Quarter Results
Business Wirescience

Edwards Lifesciences Reports Fourth Quarter Results

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOSVNFXzdpOUVMbVhtTmFKN3BidVRLaEtwZzNNZFFJdWRFcHl1cEJoc1RDaG1IbzdTX1kzS3JkWDhTc0Y0QjZ2OWh5QTZVYkY2Yy04c1NRNGJYUGREVGo3SVA4NWtyWk1KVUJQeDlPS3A2UVBwS0FCczdCemtodG92ZDhva0dtV0s0YXRhM0kzTEN3T2paOHBUWW9VZVZlR2E5MUZETXBwdUJHdFVa?oc=5" target="_blank">Edwards Lifesciences Reports Fourth Quarter Results</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits
Business Wiretech

Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits

<a href="https://news.google.com/rss/articles/CBMihgJBVV95cUxQdWRhNnRYeHJvVG44Q3ZHQmd1UVNVQnU1M0IyWVk1d2RoNHJfNkM2MFVOX2RHdXQzVkg1ZmhDUnhXY19Fd3VweHp2dnlSSDR0ZlhSRkpqRWs5SkU0Y0MyTnZxeTlRbmsyVUlIS0syelB3cl96RWY1dXBXOWRMMHNtM2RsYUNSWVhZR3MzbHdSZWZMTUw0TzNDa0hxSTJoOXplSl8xYWxoRnl0aFFNMkVRcDkxcDR0M0xFUjRBVmpGbnBybzdqUDdQam1ORVdKcmJab2R6YTZ2NXNXYVJNOVZRX1Y5TUF0MDQxdXlUWGE2eGpCdnl0Z2xlTmVRb0R0OEd1LWFab0Vn?oc=5" target="_blank">Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025
Business Wiregeneral

Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025

<a href="https://news.google.com/rss/articles/CBMi-gFBVV95cUxPaDRLZlNoR1J0bjVTWlZJU21MckJHQzZxbE9BeDlmdm5UM2FyU2ItTlNsZFd1MUtLYU02RWJfYUxydFg1VWs4NF9fUHlOTTg0MUQ1VDhZYnpXWHdkWWlBMWZESUFhVW1qNXluc1d0SmNPbVpTdGdqZF9ubE9lRkN3V1A1aHA4VlB3VFpNdkRZd1J1MllFb1daMDRlTHVlZ242MlhlRUozR2Y0ME85X3I5X0ZodjRTcXlBWGZ4MVF6MlBnUEFzNUdYWEZ6Ti1sbnB2ZFBHLTJCdWFiTWh1UjNYZ3NhUXctdE5LTzIxV3hYZGotaFE0ZTVCT2l3?oc=5" target="_blank">Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference
Business Wiretech

Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference

<a href="https://news.google.com/rss/articles/CBMi9wFBVV95cUxOdHBiSGpwcjFaVUJqR1B0WUF2M1J6OU1zVGdiVHZCRHhKQnIyenBZalVWVGFId0RVUzNmV3Voc2RvWThIR21XV1d4WlE0NDJ5bVBHdUI0QjdBMGFhTDNieGxUMFJsSFNtLXNsVjdtLW9lSGFqbzl2OF9EZWpvR2phZTVGN2FZSzh4QlpON1Z2OU8tUlFCa0J6Y0g4NUhOZ1owNUZ4VzMzbVUxR1ZBczlPbXp0Wk8yOHZ5SHBWcWFZT1FHUEktRFBUXzZFV3Z4enpMWVpsOEgybXpsSGJYdGYxQ1hnVk9tcTJuTTdZSVJGZTJYNkhZeVVj?oc=5" target="_blank">Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Edwards shares superior long-term outcomes from TAVR studies
MassDevicegeneral

Edwards shares superior long-term outcomes from TAVR studies

<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE0xTkEtUDB4ODJONnRNZWlwaEFtUWpFTTM5dGlKT3RBVDEwcXBoVEVMaFhfNFAtMWVlakZUZ3BTS1pmME9kR0U3OTM2c3FQV1lHRlQ1U2ZPV3lnamc2MXh4MEhhclFNTVM1LVJkMm0zbWFnZTRuWHFnVEZR?oc=5" target="_blank">Edwards shares superior long-term outcomes from TAVR studies</a>  <font color="#6f6f6f">MassDevice</font>

Read Full StoryMore like this
Edwards celebrates double-digit TAVR sales growth in Q4
Cardiovascular Businessgeneral

Edwards celebrates double-digit TAVR sales growth in Q4

<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxQWXIzVVFJczRuSjVPUVdKY0gxNndoYlRweTFNXzl4RGhxYUhtOWU3aG81VlhoaHZ5aW1HNkI1RUR3VGN3NWdXRFVSSUZ0c19MMENva0tZcnA5RkttRHBoS0lfNjl5dldyb0c1bTRGSXNaMFd3d1RKVnRISjJRMUtxTk1LLVdjOFFabXFUNnFhZ0NvVnktNGNOc3R2Ri1VbnA3UV8waUd3cHhHekUyM1V1c3NkNms3OG0tOFRNRDJ0N0wzaTRpeGZJZVBSY0o4dw?oc=5" target="_blank">Edwards celebrates double-digit TAVR sales growth in Q4</a>  <font color="#6f6f6f">Cardiovascular Business</font>

Read Full StoryMore like this
Five-year Data from Partner 3 Trial Demonstrate Excellent Survival for Patients Receiving Edwards Sapien 3 Valve
Diagnostic and Interventional Cardiologygeneral

Five-year Data from Partner 3 Trial Demonstrate Excellent Survival for Patients Receiving Edwards Sapien 3 Valve

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxQZmhGVEhUdDZtajV2UHdENnJZb3JxOTA3VUtTcjh2Tm00VHBhNm9pa1h4SzkwMTgyd0xQaWlZMGVZSmx5SlBlYnQ3UjRJS2VlRUNFZUZyeVBKMElJRXBReVBIdVBfekMzWEZJY0ZOUlZtWkhVaERQR1FlMFpOUk1lMXZxLW1jNkxnVGxkQ2dJdnpHc0NfSmZZNlV0NWpzNUxSNy1jMnRIMENCenRzS3ZFbUI0cWZ3eTNtbVJweHpQQXBqS3M?oc=5" target="_blank">Five-year Data from Partner 3 Trial Demonstrate Excellent Survival for Patients Receiving Edwards Sapien 3 Valve</a>  <font color="#6f6f6f">Diagnostic and Interventional Cardiology</font>

Read Full StoryMore like this
Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial
TCTMD.comgeneral

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNT1NDMm82SndZMWR6ZWFReWZoWXdQSTh6T1dvSmZxT1hSdmFIT0NGUmZvMXNrc2RPWGg3eVVRdl9tcjFhYlVEU2xaaERYSGNoaENKZTlyS1pIOFJleXVWdUNmc3hiM25CSG5zNmYwaHlNdzVHVURuVGFlQlhqaWNQbmtDSTI2UGxQT3hiTldpN25lOGZ6UDZNZFptVWlSaFE?oc=5" target="_blank">Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial</a>  <font color="#6f6f6f">TCTMD.com</font>

Read Full StoryMore like this
PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI
TCTMD.comtech

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNa1FkU0dCS1RIakJKTW9CTHF0V0J1SjZmcXJpVnBqRGRyQ1J5U2RKMmRkSHJFOXUtN1I2ZHpONWtnZ21TeDRZYzNIZlI0WHZ1RmNxQ1c2OVlHZ3owVG4wTjJfcV9ER19hVkdocklJbmJrNFF3YlpSUVYzTEpoRXRtQWZndFRVVTlhNHFWUE9YbHdQUQ?oc=5" target="_blank">PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI</a>  <font color="#6f6f6f">TCTMD.com</font>

Read Full StoryMore like this
Balloon-Expandable TAVR Has Struggles Evident at 10-Year Follow-Up
MedPage Todaygeneral

Balloon-Expandable TAVR Has Struggles Evident at 10-Year Follow-Up

<a href="https://news.google.com/rss/articles/CBMie0FVX3lxTE1YQ3RCUjFrdS05dzl6MmljeF9rS1gxY0gyM3c2cWsyZmtwdU8zMHNQd2RQbVlhQWJWSXpaZEloSU1kSmh4TkZzNUxhZDQ1SWM1VkRVX0lVN3ZBa2Ntc0dCaXlDRDRPUHFHWi1uQ2ZzLXlJTmp6VTgtVXhZdw?oc=5" target="_blank">Balloon-Expandable TAVR Has Struggles Evident at 10-Year Follow-Up</a>  <font color="#6f6f6f">MedPage Today</font>

Read Full StoryMore like this
Edwards Lifesciences misses EPS estimate by $0.04, surpasses revenue prediction
MassDevicescience

Edwards Lifesciences misses EPS estimate by $0.04, surpasses revenue prediction

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxPYlhjaHo0WVhCOFN4ZVM0ZlRob0FlbjVjRWgyU0JKTVhBVmtxYkhlVnNHNWYzN0NPUlNsanN5NlBNZjg4blBfYmJCQkt1a3p1b1ZheEd4MGVGYkZCUGJhM2dhSk1udDM5RWJHdmNrMmRnY3AwQ2Foc0RiUXZpTVpfTmlMR0hfS3BDR2IxNEcxaUxNb25CZ1c0ajFpSmJjN1RGYUI2ZEdWSjI?oc=5" target="_blank">Edwards Lifesciences misses EPS estimate by $0.04, surpasses revenue prediction</a>  <font color="#6f6f6f">MassDevice</font>

Read Full StoryMore like this
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years
NEJMgeneral

Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE1rajhCZGtjVjZUZnQ3TEVqRWZrUnBMWjJkY3dNVFR4WXZRTzlhT3lWalROTEMxN0JkdEJialBQOEJtNmJNNl9ESGo5U01iRUVQRnhBNFFTZjhWM3lMQ3JJeA?oc=5" target="_blank">Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
Midterm TAVR Data Turn Muddy: Will 10 Years Even Suffice for a Verdict?
MedPage Todaygeneral

Midterm TAVR Data Turn Muddy: Will 10 Years Even Suffice for a Verdict?

<a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE1jbzNtRG9SYVl4VEZHQWtZRTU2S0NzUkVqdWtHZFNuRUNxNFppNU00UnNWcHRiYllOQWR4ZmF0cmhWeElOcmlDeVBJNk9qd3EzWldEdC1IdFNHWm9CblZHWXBrZXA5dw?oc=5" target="_blank">Midterm TAVR Data Turn Muddy: Will 10 Years Even Suffice for a Verdict?</a>  <font color="#6f6f6f">MedPage Today</font>

Read Full StoryMore like this
Solid Durability Seen With Surgical Resilia Tissue Aortic Valve
TCTMD.comgeneral

Solid Durability Seen With Surgical Resilia Tissue Aortic Valve

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxQakRsanRkM1JKTXNiTzBJUmZONW9HYUY3MVhqdnBwYnhzVkRsTnFJQU5xaVNjaURRVXZmdVJIV1FLcXMwLVh6dkRkeUdfb2hRNjJxUWtzaS10UDZIb3pIOGhJeG90cnJqVENyTTNHdWNKQkRPNjdQSU5aOFBjWTg3NWp2VFpKN2RNb0szelh3?oc=5" target="_blank">Solid Durability Seen With Surgical Resilia Tissue Aortic Valve</a>  <font color="#6f6f6f">TCTMD.com</font>

Read Full StoryMore like this
"Edwards has 10-year data" — Live Google News Trends & Headlines